Executive Debra Patt of Texas Oncology discusses how the IICM+ AI tool demonstrates a higher C-index for predicting distant cancer recurrence.
1 report, 1 independent
Updated Sun 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Executive Debra Patt of Texas Oncology discusses how the IICM+ AI tool demonstrates a higher C-index for predicting distant cancer recurrence.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Texas Oncology
network of cancer doctors in Texas, Oklahoma and New Mexico
Nothing else this week.